Login

Componenta as an Investment - Investor Day 28.11.2022| Sami Sivuranta , CEO of Componenta 00:10:00

Share On Facebook Share On Twitter

Sami Sivuranta is President/CEO/IR at Componenta OYJ.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Seafaring Solutions: Navigating Integration Challenges and Expanding Passenger Travel in the Philippines
00:10:00
China's Commodities Outlook: Managing Expectations Amidst Global Energy Transition
00:10:00
Comacchio Spa: Training the Next Generation of Specialized Construction Operators
00:10:00
Charting the Future: ESG, Active Management, and the Blockchain Revolution| Hanneke Smits, CEO , The Bank of New York Mellon Corporation.
00:10:00
Strategy is not timing but time in the market that is important.|Professor Jon Rushman,INVESTMENT COMMITTEE,Walden Capital Partners, L.P.
00:10:00
Jun Waide on VENTENY’s Role in Advancing Indonesia's MSMEs and Workforce Well-being | Junichiro Waide, CEO, PT Venteny Fortuna International.
00:10:00
Air France-KLM CEO Benjamin Smith at Skift Global Forum 2019 | Benjamin Smith, CEO, Air France-KLM .
00:10:00
Understanding Just Transition in Energy Policy: Global Insights and Implications
00:10:00
Marathon Asset Management CEO Bruce Richard shares his Federal Reserve expectations on 'Money Movers'.
00:10:00
Waterberg Palladium Project Overview: Unveiling the World's Premier Undeveloped Palladium Asset
00:00:00
ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:10:00
Pelion invests in CEOs and tZERO's recent influence|Matt Mosman,Partner,Pelion Venture Partners

© 2026 Nehu